Fujian Haixi Joint Pharmaceutical Co., Ltd. is a prominent chemicals company based in China, specializing in the development and manufacturing of high-quality pharmaceutical products. The organization is dedicated to innovation and excellence in the pharmaceutical industry, striving to deliver solutions that enhance global healthcare while fostering a professional and collaborative work environment.

Founded in 2012 and listed on the HKEX, Haixi Pharmaceuticals Co., Ltd. has its headquarters in China and operates fully integrated activities in R&D, manufacturing, sales, and marketing. The company boasts several products that rank among the top two in the Chinese market, generating significant revenue. With a robust pipeline of first-in-class innovative products under clinical development, including treatments for osteosarcoma and AMD, Haixi is actively expanding its international presence.